Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Elecoglipron

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AZ Oral GLP-1 Shows Competitive Phase 2 Efficacy
    AZ Oral GLP-1 Shows Competitive Phase 2 Efficacy

    09 Jun 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ada-astrazenecas-oral-glp-1-shows-competitive-efficacy-standard-tolerability-phase-2

    FIERCE BIOTECH
    09 Jun 2026
    Share Share
    AstraZeneca unveils data behind Phase III-bound oral GLP-1
    AstraZeneca unveils data behind Phase III-bound oral GLP-1

    08 Jun 2026

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2026/elecoglipron-an-oral-small-molecule-glp-1-ra-moves-to-phase-iii-programme.html

    PRESS RELEASE
    08 Jun 2026
    Share Share
    Elecoglipron Clinical Data to Be Presented at ADA 2026
    Elecoglipron Clinical Data to Be Presented at ADA 2026

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601751467/en/Multiple-Clinical-Trial-Data-for-Elecoglipron-AZD5004ECC5004-an-Oral-GLP-1-Receptor-Agonist-to-be-Presented-at-ADA-2026

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.